CareDx (CDNA) Competitors

CareDx (NASDAQ:CDNA) and RadNet (NASDAQ:RDNT) are both medical companies, but which is the superior stock? We will contrast the two businesses based on the strength of their dividends, institutional ownership, earnings, valuation, media sentiment, profitability, analyst recommendations, community ranking and risk.

Does the media refer more to CDNA or RDNT?

In the previous week, RadNet had 15 more articles in the media than CareDx. MarketBeat recorded 19 mentions for RadNet and 4 mentions for CareDx. CareDx's average media sentiment score of 1.66 beat RadNet's score of 0.61 indicating that CareDx is being referred to more favorably in the media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
CareDx	3 Very Positive mention(s)	0 Positive mention(s)	0 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Very Positive
RadNet	7 Very Positive mention(s)	2 Positive mention(s)	6 Neutral mention(s)	2 Negative mention(s)	0 Very Negative mention(s)	Positive

Does the MarketBeat Community prefer CDNA or RDNT?

CareDx received 87 more outperform votes than RadNet when rated by MarketBeat users. However, 66.23% of users gave RadNet an outperform vote while only 65.87% of users gave CareDx an outperform vote.

Company	Underperform	Outperform
CareDx	Outperform Votes 442 65.87%	Underperform Votes 229 34.13%
RadNet	Outperform Votes 355 66.23%	Underperform Votes 181 33.77%

Is CDNA or RDNT more profitable?

RadNet has a net margin of -0.25% compared to CareDx's net margin of -45.90%. RadNet's return on equity of 4.29% beat CareDx's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
CareDx	-45.90%	-53.70%	-30.42%
RadNet	-0.25%	4.29%	1.45%

Do institutionals and insiders hold more shares of CDNA or RDNT?

77.9% of RadNet shares are owned by institutional investors. 4.9% of CareDx shares are owned by insiders. Comparatively, 5.1% of RadNet shares are owned by insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a stock is poised for long-term growth.

Which has higher earnings and valuation, CDNA or RDNT?

RadNet has higher revenue and earnings than CareDx. CareDx is trading at a lower price-to-earnings ratio than RadNet, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
CareDx	$333.79M	3.05	-$190.28M	$1.02	18.00
RadNet	$1.83B	2.05	$3.04M	$0.03	1,689.00

Which has more risk and volatility, CDNA or RDNT?

CareDx has a beta of 1.95, meaning that its share price is 95% more volatile than the S&P 500. Comparatively, RadNet has a beta of 1.85, meaning that its share price is 85% more volatile than the S&P 500.

Do analysts recommend CDNA or RDNT?

CareDx presently has a consensus price target of $31.83, indicating a potential upside of 73.43%. RadNet has a consensus price target of $73.25, indicating a potential upside of 44.56%. Given CareDx's higher probable upside, analysts clearly believe CareDx is more favorable than RadNet.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
CareDx	0 Sell rating(s)	3 Hold rating(s)	4 Buy rating(s)	0 Strong Buy rating(s)	2.57
RadNet	0 Sell rating(s)	0 Hold rating(s)	3 Buy rating(s)	2 Strong Buy rating(s)	3.40

Summary

RadNet beats CareDx on 11 of the 19 factors compared between the two stocks.